PRECLINICAL EXPERIENCES WITH MAGNETIC DRUG TARGETING - TOLERANCE AND EFFICACY AND CLINICAL-EXPERIENCES WITH MAGNETIC DRUG TARGETING - A PHASE-I STUDY WITH 4'-EPIDOXORUBICIN IN 14 PATIENTS WITH ADVANCED SOLID TUMORS - REPLY
As. Lubbe, PRECLINICAL EXPERIENCES WITH MAGNETIC DRUG TARGETING - TOLERANCE AND EFFICACY AND CLINICAL-EXPERIENCES WITH MAGNETIC DRUG TARGETING - A PHASE-I STUDY WITH 4'-EPIDOXORUBICIN IN 14 PATIENTS WITH ADVANCED SOLID TUMORS - REPLY, Cancer research, 57(14), 1997, pp. 3064-3065